Cicada Health Tech Community

We are very honoured to partner with JDRF Australia supporting the next generation of breakthrough projects that will make a positive impact for people living with Type 1 Diabetes.

Expressions of Interest for the NSW Health Aboriginal Heart Health Grants are closing soon. This targeted funding will support high impact Aboriginal-led research to improve cardiovascular health outcomes for Aboriginal peoples and build the capacity of Aboriginal communities and researchers in cardiovascular focused research within NSW. Learn more about the Aboriginal Heart Health Grants and how to apply https://lnkd.in/g5Z3BG3E

Wow, what another incredible year, working with NSW Government on the NSW Health Commercialisation Training Program (HCTP)! We couldn’t be more thrilled to share the tremendous amount of growth HCTP has created during its almost 4 year run with Cicada Innovations in the current iteration. The NSW Health Commercialisation Training Program, from NSW Health, presented by Cicada Innovations, offers researchers, scientists, clinicians, and entrepreneurs working on medtech and biotech innovations a flexible, stage-specific approach that allows participants to join at any point. This year, we had the honour of celebrating the 10th Anniversary of the NSW Health Commercialisation Training Program through the NSW Health Showcase! And witnessed in those 10 years: - $134 million generated in funding through grants or private investment  - 350+ medical entrepreneurs enrol in  HCTP - 40 companies launched, taking 67 technologies to market  - 3,400+ participants join our HCTP cohort - 31 initiated clinical trials  - And over 23,000 patients have benefitted from the cutting-edge technology nutured in these programs! This year, we delivered 10 seminars and courses across the HCTP, that’s 26 days spent thinking of innovation… literally…. enough hours to fly to London 26 times! We also had over 400 people join our cohort this year. The equivalent of an Airbus A380! We would also like to extend our congratulations to our NSW Health Commercialisation Training Program alumni John Shanks 🦑, Luca Modenese and Martina Barzan on winning the 2024 Innovation Catalyst Awards from UNSW Tyree Foundation Institute of Health Engineering! 🎉 Congrats to Desiree D. for winning the national pitch competition in the area of ‘Women's Economic Empowerment. Shoutout to ShanShan Wang, from Roam Technologies (roamtech.ai) who was a Tech 23 Alumni this year and won the Future Leader Award at the 2024 HCTP Showcase awards. We would also like to congratulate the other HCTP Showcase award recipients, Veysel Kayser, who won the Emerging Innovator Award and Danielle Fisher GAICD from BIENCO, who won the Best Innovation Award. We would also like to mention Outcomes Nutrition (Tummily), who joined us through the HCTP program and has gone on to become a Cicada Innovations Health Tech Hub resident!  Thank you to the NSW Government, NSW Medical Research,  Jean-Frederic Levesque, Anne O'Neill FTSE and the OHMR HCTP team. None of this would have been possible without the hard work of the Cicada Innovation team Dr Katja Beitat, Alex Vellere, Beatrice Carmen, Archie Dell.  We are grateful to our partners for their support, and a huge thank you to all our mentors, speakers, and facilitators for helping platform healthcare entrepreneurs at every stage of their commercialisation journey. Learn more about the HCTP program here: https://lnkd.in/gB7feiBz #health #healthcare #deeptech #innovationtech #HCTP #NSWHealth #australianstartups #NSWGovernment

Again this year, representatives from across the Westmead Health Precinct featured heavily at the annual Westmead Health and Innovation District Conference. Hosted by Business Western Sydney and held in Parramatta, nearly 200 people attended, including from all levels of Government, private industry, and not-for-profit. The Hon Ryan Park MP, Minister for Health and The Hon Anoulack Chanthivong MP, Minister for Industry and Trade, Minister for Innovation, Science and Technology, headlined the list of speakers. From the Westmead ecosystem: 👉 Western Sydney Local Health District Chief Executive, Graeme Loy provided an update on Westmead’s Health Enterprise Zone (HEZ), the 400,000m2 of developable land at the Westmead Health Precinct. 👉 Associate Professor Greg De Moore reflected on the 175th anniversary of Cumberland Hospital and the development of mental health care over time, including the development of the new Integrated Mental Health Complex at Westmead. 👉 Children's Medical Research Institute's Director, Professor Roger Reddel shared an overview of the latest CMRI research in stem cell, gene therapy and cancer. 👉 Associate Professor James Chong shared the opportunities and challenges of commercialising research as a clinician. 👉 Cicada Innovations' General Manager, Lilly Bojarski PhD spoke about the benefit incubators and shared workspaces have in driving innovation. Our thanks to David Borger and the Business Western Sydney team for facilitating another interactive conference. 2025 promises to be a big year.

And that's a wrap! What a fantastic way to end 2024 Cicada Innovation’s Healthtech Hub’s masterclass series on the topic 'Navigating Healthtech Landscape: Investor engagement & Optimal Timing'! 🎉 Thank you to Mark Flynn (Global Edge Medtech Consulting) for facilitating an engaging class and panel discussion last Wednesday, and to Kea Dent, MBA, GAICD, RAC (KD&A Pty Ltd), Jeremy Chrisp (Chrisp & Associates) and Anne O'Neill FTSE (NSW Medical Research Office of Health and Medical Research) for offering the well rounded perspectives from medical devices, therapeutics, medical and regulatory affairs and NSW health strategies. Such important assurance that our healthtech start-up founders are well supported. You’re been heard! Key takeaways from this event? - There is no for your health tech strategy - value proposition is unique for each stakeholder - Non-dilutive funding though competitive and could be small - but they can help you do things that private capital cannot - Aligning your marketing strategy with your regulatory strategy from the start is key - Invest in the relationships and partnerships for your future business through networking (literally and figuratively!) That’s a wrap for 2024 - the next masterclass will resume in February 2025, with the not-to-be missed topic on Non-dilutive funding options for your health technologies and How to secure them. Stay tuned for more updates! Learn more about Cicada Innovations Healthtech Hub here: https://lnkd.in/gNsyrYTf #healthtech #medicaldevice #startup #entrepreneurship #innovation #Nondilutive #valueproposition #marketing #regulatory

At Cicada Innovations, we love working with the next generation of medtech researchers and entrepreneurs. Thanks University of Technology Sydney for inviting us.

Wow, what a year it’s been for our  Health Tech Hub incubator! Since launching the Cicada Innovations HealthTech Hub this year, we had the privilege of welcoming The Hon. Anoulack Chanthivong MP and Uncle Graham Davis at the official HTH opening of our incubator! Shoutout to Graeme Loy for kicking off our first networking night with opening ceremony remarks on behalf of the Westmead Health Precinct! We have had the privilege of welcoming 11 new residents and community members this year! Shoutout to our ecosystem:  iiShield Hi-fi Orthopedics Outcomes Nutrition (Tummily) World Data Exchange Latent Knowledge Triggar Health  Pentalym Observa Care VVMF - Viral Vector Manufacturing Facility Antimicrobial Plasmid Therapy  QA/RA Dynamics Our resident, Joanne Cooper, the CEO of World Data Exchange, also won a special recognition at the 2024 Australian Women in Security Awards! World Data Exchange was also accepted into the Going Global Export Program from Investment NSW and attended BIO2024.  None of this would have been possible without the hard work of the Health Tech Hub team - Group Executive Dr Katja Beitat Beitat, General Manager Lilly Bojarski, Program Manager Angelica Lau, Ph.D, and Community Coordinator Kimberley Steel.  We are grateful to our partners for their support - NSW Government and Brandon Capital, helping platform our budding HTH community, at every stage of their commercialisation journey.  Our General Manager, Lilly Bojaski, was also our HTH hub ambassador, attending the AusBiotech National Conference 2024, and our CEO, Sally-Ann Williams FTSE, led a panel discussion on driving innovation in healthcare precincts at the Westmead Research and Innovation Conference. Most recently, we were pleased to welcome Sam Wheatley and Aunty Grace Mumbler, who kicked off the proceedings for us at the HTH Showcase, which celebrated the success of our residents and community! Over 400 people joined our Elevate and Masterclass series this year. The equivalent of an Airbus A380! The success of our programs owes so much to the work of our incredible mentors! Shout-out to Prashanth Rajan (Brandon Capital) for sharing your insights and experiences with our hub community! Also, thank you to our Fast Start coaches, Dr. Silvia Pfeiffer and Rob McInnes, for being at every stage of the journey of our Fast Start graduates. Shout-out to our Fast Start graduates—Professor Jon Iredell and Dr. Kamal Muhammad Kamruzzaman, PhD, FASM leading the way for their The Westmead Institute for Medical Research-based Plasmid Therapy for antimicrobial resistant infections and Joanne Cooper. Cicada Innovations' HealthTech Hub provides exclusive access to a vibrant community of health tech innovators. Residents enjoy a range of benefits, from state-of-the-art facilities to access to commercialisation programs and networking connections. Head here to learn more: https://lnkd.in/gViVTZmu #deeptech #healthcare #health

Does your organisation pursue or enable the translation, commercialisation, production or the clinical delivery of cell and gene therapies? This means you could be investing to: 🔸 grow your cell and gene product pipeline 🔸 acquire a cell and gene company 🔸 expand your cell and gene workforce 🔸 extend your cell and gene clientele 🔸 buy more equipment or floor space 🔸 provide education, skills and training 🔸 enable SMEs, seeking ROI / equity / shares And we are keen to hear from you. Australia’s Cell and Gene Catalyst has partnered with Deloitte to better understand the future growth potential for cell and gene therapies in Australia. Tell us where you think we’re heading as a sector Down Under. Scan the QR code to complete the survey. 👇🏽 The Catalyst is a joint venture co-led by Medicines Australia and AusBiotech. #AusCatalyst

Your journey to health tech mastery starts here! We’re back and ready than ever to kick off another HCTP Specialisations series!  With over 2000 participants since 2021, the NSW Health Commercialisation training program paved the way for health tech innovators from around the state to commercialise their ideas successfully. In 2025, we will commence four specialisation courses for innovations that have been established and validated.  These 3-day workshops deep dive into your specific sector when you are planning how to access your chosen market.  You will walk away with new connections and strategies to accelerate your growth. Does this sound like you? Sign up today: https://lnkd.in/g3VDWpm7 #medicaldevice #commercialisation #healthtech #healthcommercialisation #medtech NSW Medical Research NSW Government

🚨 One week to go! Expressions of Interest for CUREator+, a national biomedical and digital health technology incubator program, close soon. 📅 Submit your EOI by 12pm AEDT, Wednesday 4 December. With up to $5 million in non-dilutive funding available, CUREator+ supports the preclinical, clinical, and commercial development of: 🔹 Medical and connected devices 🔹 Digital health technologies 🔹 Therapeutics Start grant application 👉🏿 https://lnkd.in/g7FDwCJm Learn more about the program 👉🏼 https://lnkd.in/g2x5_Cbs CUREator+ is delivered in partnership with ANDHealth with funding from the MRFF BioMedTech Incubator (BMTI) program.